Dulcolax and Levocarnitine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Levocarnitine (levocarnitine). Common drug interactions include abdominal discomfort among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Levocarnitine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Levocarnitine?

Levocarnitine has active ingredients of levocarnitine. It is often used in mitochondrial myopathy. eHealthMe is studying from 3,332 Levocarnitine users. Check the latest studies of Levocarnitine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

11 people who take Dulcolax and Levocarnitine together, and have interactions are studied.

Dulcolax and Levocarnitine drug interactions.

What are the common drug interactions of Dulcolax and Levocarnitine, by gender? *:

female:

  1. Abdominal discomfort
  2. Aggression
  3. Drug ineffective
  4. Frequent bowel movements
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting
  7. Adverse drug reaction
  8. Hypophagia (reduced food intake)
  9. Influenza
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

male:

  1. Asthenia (weakness)
  2. Chronic kidney disease
  3. Dehydration (dryness resulting from the removal of water)
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Muscle tightness
  6. Renal failure (kidney dysfunction)
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

What are the common drug interactions of Dulcolax and Levocarnitine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Muscle tightness
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Diarrhoea
  4. Aggression
  5. Drug ineffective
  6. Frequent bowel movements
  7. Vomiting
  8. Influenza

10-19:

  1. Hypersomnia (excessive daytime sleepiness (eds))
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Abdominal discomfort
  4. Diarrhoea
  5. Nausea (feeling of having an urge to vomit)
  6. Adverse drug reaction
  7. Hypophagia (reduced food intake)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Asthenia (weakness)
  2. Dehydration (dryness resulting from the removal of water)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 27.27%
  3. Hypersensitivity: 3 people, 27.27%
  4. Pain: 3 people, 27.27%
  5. High Blood Pressure: 2 people, 18.18%
  6. Facial Spasm (involuntary muscle contractions face): 2 people, 18.18%
  7. Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 2 people, 18.18%
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 18.18%
  9. Drooling (drop saliva uncontrollably from the mouth): 2 people, 18.18%
  10. Diarrhea: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Levocarnitine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dulcolax and Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dulcolax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levocarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dulcolax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levocarnitine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl and levocarnitine (the active ingredients of Dulcolax and Levocarnitine, respectively), and Dulcolax and Levocarnitine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: